3 unchanged sentences
and CIPLA USA (“CIPLA”) submitted to the FDA an ANDA (ANDA No.
−Removed: 218028) for a generic version of PEDMARK ® (sodium
−Removed: thiosulfate solution) that contained Paragraph IV Certifications on two of our patents covering PEDMARK ® :
+Added: 218028) for a generic version of PEDMARK ® (sodium thiosulfate solution) that contained Paragraph IV Certifications on two of our patents covering PEDMARK ® :
the OHSU licensed ‘190 Patent, expiration date January 2038;
31 unchanged sentences
On July 14, 2025, the court issued its Order on Claim Construction on two claim terms in dispute, adopting our proposed constructions for both.
+Added: On August 25, 2025, the CIPLA entities filed an Answer and Counterclaims to the complaint, alleging that the ‘026 Patent was invalid, not infringed, and/or unenforceable.
The suit is ongoing .
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.